Nasdaq Biotechnology Ishares ETF (IBB)
$107.94 1.51 (1.38%)
11:55 EDT IBB Stock Quote Delayed 15 Minutes
Previous Close $0.00
Market Cap 9.39B
PE Ratio -
Volume (Avg. Vol.) 1.37M
Day's Range 107.46 - 109.41
52-Week Range 89.01 - 122.97
Dividend & Yield 0.31 (0.29%)
IBB Stock Predictions, Articles, and Nasdaq Biotechnology Ishares ETF News
- From InvestorPlace
- From the Web
Netflix, IBM, Abbott Labs, Domino's Pizza and the IBB ETF were our top stock trades to watch for Thursday, the last trading day this week.
AZN stock is great to own, but you should choose your entry points carefully, as AstraZeneca has some short-term risks ahead.
Regardless of political risks, there are still valuable opportunities in some healthcare stocks. Here are three to consider.
The charts for the IBB ETF in multiple time frames suggest the recent rally in biotech stocks is overdone for the time being.
This morning I am recommending a bearish trade on the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).
This morning I am recommending a bullish trade on the iShares Nasdaq Biotechnology ETF (NASDAQ:IBB). I like the biotech sector, and it has generally been holding up well during the recent volatility.
Gilead stock is cheap selling at 11 price-earnings ratio. And it's coming into a long-term support zone. Catch the falling butter knife.
Pfizer renewed the drug price hike cycle after it raised them for around 40 products. If other biotech stocks follow, profits will soar.
PFE is a proven survivor stock and it now sits on a potential long term technical breakout. Go long its potential with confidence.
Large-cap biotech stocks as a group rallied along with the broader stock market on Wednesday. While so doing, some big names like AMGN stock broke past key near-term technical resistance.
The biotech sector peaked in 2015. While it bounced back from lows, biotech ETFs give investors exposure to the sector as it recovers.
Both biotech stocks and big pharma stocks involve a different mindset. Treat biotech stocks like options and big pharma stocks like ETFs.
The markets had a big week and bulls are looking to press their luck and fatten their wallets. Here are our top stock trades for Monday.
Investors looking for low-cost, diversified exposure to growth stocks are wise to consider one of the 7 best growth ETFs on the market.
TEVA stock has potential that is purely technical. Teva Pharmaceutical is showing a breakout that would send it 25% higher from here, so now is the time to go long.
These biotech and pharmaceutical stocks are soaring insanely high right now. Here's what investors should know about each of these hot stocks to buy.
CELG stock continues to notably lag some of its peers in the biotechnology group, but this could soon change and set up a juicy Celgene trade.
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!